Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
University of Washington
University of Washington
City of Hope Medical Center
Mayo Clinic
City of Hope Medical Center
City of Hope Medical Center
Mayo Clinic
Roswell Park Cancer Institute
Washington University School of Medicine
Roswell Park Cancer Institute
Northwestern University
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center